Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Stryker Corp (NY: SYK )

337.38 -1.49 (-0.44%)
Streaming Delayed Price Updated: 3:44 PM EDT, Apr 30, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Stryker Corp

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Expert Ratings for Stryker
Via Benzinga
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
The Pros Got It Wrong: 3 Stocks to Sell Despite Recent Upgrades
These three stocks to sell may be good picks for nimble traders, but for long-term investors, it may be time to put them aside. 
Via InvestorPlace
Here's How Much You Would Have Made Owning Stryker Stock In The Last 20 Years
Via Benzinga
3 Supercharged Dividend Stocks to Buy if There's a Stock Market Sell-Off
These three top-notch stocks would make great additions to any dividend portfolio. 
Via The Motley Fool
Why Stryker Stock Rose Today
Stryker Corporation (NYSE: SYK) shares traded higher on Monday. 
Via Benzinga
What's Going On With Stryker Stock?
Stryker Corp (NYSE: SYK) shares are trading lower by 1.4% to $256.46 Thursday morning. 
Via Benzinga
How Is The Market Feeling About Stryker?
Via Benzinga
Here's How Much You Would Have Made Owning Stryker Stock In The Last 20 Years
Via Benzinga
Why Stryker (SYK) Stock Fell 5% Wednesday
Stryker Corp (NYSE: SYK) shares fell 5.26% to $260.05 Wednesday. The stock experienced weakness after the FDA established a Digital Health Advisory Committee. 
Via Benzinga
Exposures Product Safety
Looking At Stryker's Recent Unusual Options Activity
Via Benzinga
Three Of Our Top Picks For Your Healthcare Portfolio
Amidst macro uncertainty, healthcare stocks should outperform. 
Via Talk Markets
Peering Into Stryker's Recent Short Interest
Via Benzinga
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Here's How Much $1000 Invested In Stryker 20 Years Ago Would Be Worth Today
Via Benzinga
Looking Into Stryker's Recent Short Interest
Via Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Stryker Bull Expects Upside For Medtech Stock In '24, Ortho To Be 'Higher For Longer'
Shares of Stryker Corp (NYSE: SYK) continued to rise in early trading on Tuesday, after ending last week with gains. 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 5, 2023
Via Benzinga
If You Invested $1000 In This Stock 20 Years Ago, You Would Have $7,500 Today
Via Benzinga
Life Science Mutual Funds Compared To ETFs And What Is In Your Portfolio?
It is important to track sectors of the market because trends to create volatility. For example the COVID pandemic created a diagnostics and vaccine revenue bubble that dissipated over several months. 
Via Talk Markets
Topics ETFs
Exposures COVID-19
Boston Scientific Stock Gets 81 RS Rating After Profit Pops 56% In Year
Boston Scientific stock rose from a 34.98 low on June 16, 2022, amid the bear market, to an all-time high 54.66 close on June 22 this year. 
Via Investor's Business Daily
Stryker, NextEra Energy And A Stock Down 18% In Past Month: CNBC's 'Final Trades'
On CNBC’s "Halftime Report Final Trades," Josh Brown of Ritholtz Wealth Management said he is sticking with NextEra Energy, Inc. (NYSE: NEE) 
Via Benzinga
$1000 Invested In Stryker 15 Years Ago Would Be Worth This Much Today
Via Benzinga
Is This MedTech Giant a Buy for Dividend Investors?
The company stands out as a titan of the medical devices industry. 
Via The Motley Fool
Where Stryker Stands With Analysts
Via Benzinga
Stryker, Wynn Resorts And A Chinese Tech Giant Expanding AI Capabilities: CNBC's 'Final Trades'
On CNBC’s "Halftime Report Final Trades," Stephen Weiss of Short Hills Capital Partners named Alibaba Group Holding Limited (NYSE: BABA) as his 
Via Benzinga
Nikola's Abrupt CEO Transition, Carl Icahn Led Icahn Enterprises Cuts Dividend Payout, FDA Rejects Mesoblast's Cell Therapy For Kids: Today's Top Stories
Wall Street Journal 
Via Benzinga
Stryker Stock Gets A Boost From Annual Guidance Hike On Better Than Expected Q2 Earnings: The Details
Stryker Corporation (NYSE: SYK) reported Q2 sales of $5 billion, up 11.2% Y/Y (+11.9% in constant currency), beating the consen 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.